Do estrogen effects on blood vessels translate into clinically significant atheroprotection?
Pradhan
Sanjeev
S
Department of Vascular Surgery, Yale University School of Medicine, New Haven, CT 06520, USA.
Sumpio
Bauer E
BE
D000818:Animals; D001161:Arteriosclerosis / Q000473:pathology* / Q000517:prevention & control; D002979:Climacteric / Q000187:drug effects*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D004730:Endothelium, Vascular / Q000473:pathology; D015914:Estrogen Replacement Therapy / Q000009:adverse effects; D004966:Estrogens, Conjugated (USP) / Q000009:adverse effects / Q000494:pharmacology; D006801:Humans; D008055:Lipids / Q000097:blood; D017258:Medroxyprogesterone Acetate / Q000009:adverse effects / Q000494:pharmacology
D004966:Estrogens, Conjugated (USP); D008055:Lipids; D017258:Medroxyprogesterone Acetate